One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v122.21.2820.2820
Copy DOI Journal: Blood |  Publication Date: Jul 7, 2021 |
 Citations: 3 |
Affiliation: The University of Texas MD Anderson Cancer Center, Délégation Paris 7, Hôpital Saint-Louis, Stanford University, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Mayo Clinic, Policlinico San Matteo Fondazione, Istituti di Ricovero e Cura a Carattere Scientifico, Incyte (United States), Tris Pharma (United States), Novartis (Switzerland), Princess Margaret Cancer Centre, Guy's and St Thomas' NHS Foundation TrustA Pooled Overall Survival Analysis of The COMFORT Studies: 2 Randomized Phase 3 Trials of Ruxolitinib For The Treatment of Myelofibrosis
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
